ENOB News and Press, Enochian Biosciences Inc. From 11/25/19

Enochian Biosciences (NASDAQ: ENOB ) is up  18%  premarket on entering into an agreement in principle to acquire an exclusive, license for a treatment under development aimed to treat the Hepatitis B Virus (HBV) infections from G-Tech Bio, LLC. More news on: Enochian Bioscience...

Agreement provides Enochian with exclusive rights to develop and commercialize a HBV treatment with a novel mechanism of action Abstract accepted highlighting the in vivo and in vitro data from preclinical studies conducted with HBV treatment will be presented at HepDART on Decem...

This article was selected to be shared with PRO+ Short Ideas subscribers - find out more here . Enochian Biosciences ( ENOB ) is a biotech company with a pre-clinical pipeline focused on the treatment and cure of HIV. Enochian has a troubled past, with a lot of management shake-ups and ...

This article was selected to be shared with PRO+ subscribers - find out more here . While everyone would love to have a cure for HIV, I have serious doubts that Enochian has much at all except a capital structure to greatly benefit it's board which owns about 65% of the company and can ...

Gainers:  Viveve Medical (NASDAQ: VIVE ) +91% . Achillion Pharmaceuticals (NASDAQ: ACHN ) +71% . Regional Health Properties (NYSEMKT: RHE ) +53% . Xenetic Biosciences (NASDAQ: XBIO ) +44% . Assembly Biosciences (NASDAQ: ASMB ) +30% . Ideal Power (NASDAQ: IPWR ) +29% . Aethlon Me...

Gainers: NF Energy Saving (NASDAQ: BIMI ) +286% . Synthesis Energy Systems (NASDAQ: SES ) +156% . Yuma Energy (NYSEMKT: YUMA ) +58% . Ideal Power (NASDAQ: IPWR ) +34% . Oncternal Therapeutics (NASDAQ: ONCT ) +31% . Bio-Path Holdings (NASDAQ: BPTH ) +21% . Enochian Biosciences (NASDA...

Gainers: Synthesis Energy Systems (NASDAQ: SES ) +81% . MOGU (NYSE: MOGU ) +20% . Purple Innovation (NASDAQ: PRPL ) +19% . Fastenal (NASDAQ: FAST ) +17% . Aerie Pharmaceuticals (NASDAQ: AERI ) +17% . Valaris (NYSE: VAL ) +16% . Mmtec (NASDAQ: MTC ) +15% . Aclaris Therapeutics (NASD...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

LOS ANGELES, June 03, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), a biotechnology company developing potentially curative and preventative genetically modified cellular and immune-therapy platforms to transform the lives of persons living with HIV and cancer patients...

Enochian developing ENOB-HV-01 an autologous cell therapy as a potentially curative treatment for HIV LOS ANGELES, March 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), a biotechnology company developing potentially curative and preventative genetically modified...